Highlights of the North American Cystic Fibrosis Conference 2011.
作者信息
Pabary Rishi, Thursfield Rebecca, Davies Jane C
机构信息
Royal Brompton & Harefield NHS Trust, London & Imperial College London, UK.
出版信息
J R Soc Med. 2012 Jun;105 Suppl 2(Suppl 2):S9-13. doi: 10.1258/jrsm.2012.12s002.
Abstract
摘要
相似文献
1
Highlights of the North American Cystic Fibrosis Conference 2011.2011年北美囊性纤维化会议亮点
J R Soc Med. 2012 Jun;105 Suppl 2(Suppl 2):S9-13. doi: 10.1258/jrsm.2012.12s002.
2
Cystic fibrosis transmembrane conductance regulator dysfunction and its treatment.囊性纤维化跨膜传导调节因子功能障碍及其治疗
J R Soc Med. 2012 Jun;105 Suppl 2(Suppl 2):S2-8. doi: 10.1258/jrsm.2012.12s001.
3
Pulmonology: CFTR modulators for cystic fibrosis.肺病学：用于囊性纤维化的CFTR调节剂
JAAPA. 2013 Feb;26(2):59-60. doi: 10.1097/01720610-201302000-00013.
4
Cystic fibrosis transmembrane conductance regulator biomarkers in 'real life': can we evaluate individual efficacy of cystic fibrosis transmembrane conductance regulator therapy?“现实生活”中的囊性纤维化跨膜传导调节因子生物标志物：我们能否评估囊性纤维化跨膜传导调节因子疗法的个体疗效？
Ther Adv Respir Dis. 2015 Aug;9(4):198-200. doi: 10.1177/1753465815579364.
5
A new era in the treatment of cystic fibrosis.囊性纤维化治疗的新时代。
Clin Med (Lond). 2014 Feb;14(1):76-8. doi: 10.7861/clinmedicine.14-1-76.
6
Cystic Fibrosis: The Dawn of a New Therapeutic Era.囊性纤维化：新治疗时代的曙光
Am J Respir Crit Care Med. 2017 Apr 15;195(8):979-984. doi: 10.1164/rccm.201606-1250PP.
7
Ivacaftor and Airway Inflammation in Preschool Children with Cystic Fibrosis.依伐卡托与囊性纤维化学龄前儿童的气道炎症
Am J Respir Crit Care Med. 2021 Sep 1;204(5):605-608. doi: 10.1164/rccm.202012-4332LE.
8
Effects of Ivacaftor in Three Pediatric Siblings With Cystic Fibrosis Carrying the Mutations G551D And F508del.依伐卡托对三名携带G551D和F508del突变的囊性纤维化儿科同胞的影响。
Arch Bronconeumol (Engl Ed). 2018 Apr;54(4):232-234. doi: 10.1016/j.arbres.2017.09.012. Epub 2017 Nov 3.
9
Remarkable progress toward new treatments for cystic fibrosis.囊性纤维化新疗法取得显著进展。
Lancet Respir Med. 2014 Dec;2(12):962-4. doi: 10.1016/S2213-2600(14)70272-3. Epub 2014 Nov 19.
10
Clinical trial research in focus: ensuring new cystic fibrosis drugs fulfil their potential.聚焦临床试验研究：确保新型囊性纤维化药物发挥其潜力。
Lancet Respir Med. 2017 Sep;5(9):681-683. doi: 10.1016/S2213-2600(17)30311-9.
本文引用的文献
1
Abstracts of the 25th Annual North American Cystic Fibrosis Conference. November 3-5, 2011. Anaheim, California, USA.第25届北美囊性纤维化年会摘要。2011年11月3日至5日。美国加利福尼亚州阿纳海姆。
Pediatr Pulmonol. 2011 Oct;46 Suppl 34(Suppl 34):106-445. doi: 10.1002/ppul.21582.
Zotero 插件